MedTrace Logo

Biomarker Guided Antibiotic Treatment in Community-Acquired Pneumonia

NCT03146182 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2017-05-10

No results posted yet for this study

Summary

The purpose of this study is to determine the efficacy of C-reactive protein and procalcitonin based guidelines versus standard of care to reduce duration of antibiotic exposure in patients hospitalized with community acquired pneumonia.

Conditions

  • Community Acquired Pneumonia

Interventions

BEHAVIORAL

CRP-algorithm

a strategy based on CRP guided antibiotic stewardship

BEHAVIORAL

PCT-algorithm

a strategy based on PCT guided antibiotic stewardship

Sponsors & Collaborators

  • Gertrud Baunbaek Egelund

    lead OTHER

Principal Investigators

  • Gertrud B Egelund, M.D. · Department of pulmonary and infectious diseases, Nordsjaellands Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-03-15
Primary Completion
2018-12-31
Completion
2019-02-28

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03146182 on ClinicalTrials.gov